Allergan (AGN) Affirms Receipt of FDA Committee Backing for Desmopressin Nasal Spray NDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/18/2024
Go back to Allergan (AGN) Affirms Receipt of FDA Committee Backing for Desmopressin Nasal Spray NDA
October 19, 2016 3:54 PM EDT
Allergan (NYSE: AGN) Wins FDA Panel Backing For Nocturia Treatment - Bloomberg
...
More